SWEDISH ORPHAN BIOVITRUM AB 06/05/2026 AGM
1Open Meeting Non-Voting
2Elect Chair of Meeting For
3Prepare and Approve List of ShareholdersFor
4Approve Agenda of Meeting For
5Designate Inspector(s) of Minutes of Meeting Non-Voting
6Acknowledge Proper Convening of Meeting For
7Receive Financial Statements and Statutory Reports Non-Voting
8Receive Presidents Report Non-Voting
9Receive Report on Work of Board and Committees Non-Voting
10Approve Financial StatementsAbstain
11Approve Allocation of Income and Omission of Dividends - No Dividend Proposed For
12.1Approve Discharge of Christophe BourdonFor
12.2Approve Discharge of Annette ClancyFor
12.3Approve Discharge of Iris Loew-FriedrichFor
12.4Approve Discharge of David MeekFor
12.5Approve Discharge of Zlatko RihterFor
12.6Approve Discharge of Helena SaxonFor
12.7Approve Discharge of Staffan SchubergFor
12.8Approve Discharge of Filippa StenbergFor
12.9Approve Discharge of Anders Ullman For
12.10Approve Discharge of Mats LekFor
12.11Approve Discharge of Katy Mazibuko For
12.12Approve Discharge of Sara Carlsson For
12.13Approve Discharge of Asa Kjellstrom For
12.14Approve Discharge of Susanna Ronnback For
12.15Approve Discharge of CEO Guido OelkersFor
13.1Approve Remuneration of Directors in the Amount of SEK 2.5 Million for Chair and SEK 820,000 for Other Directors; Approve Remuneration for Committee Work; Approve Meeting FeesFor
13.2Allow the Board to Determine the Auditor's RemunerationFor
14.1Determine Number of Members (7) and Deputy Members (0) of BoardFor
14.2Determine Number of Auditors (1) and Deputy Auditors (0)For
15.AElect Christophe Bourdon - Non-Executive DirectorFor
15.BElect Iris Loew-Friedrich - Non-Executive DirectorFor
15.CElect David Meek - Chair (Non Executive)Oppose
15.DElect Staffan Schüberg - Non-Executive DirectorFor
15.EElect Filippa Stenberg - Non-Executive DirectorOppose
15.FElect Mikael Dolsten - Non-Executive DirectorFor
15.GElect Åsa Riisberg - Non-Executive DirectorFor
15.HElect David Meek - Chair (Non Executive)Oppose
15.IAppoint the Auditors - EYOppose
16.Approve the Remuneration ReportOppose
17A.1Approve Long Term Incentive Program (Management Program)Oppose
17A.2Approve Long Term Incentive Program (All Employee Program)For
17B.1Approve Equity Plan Financing (Management Program)Oppose
17B.2Approve Equity Plan Financing (All Employee Program)For
17.CApprove (Alternative) Equity Plan FinancingOppose
18Issue Shares for CashFor
19Transfer of Own Shares on Account of the Share Program Oppose
20Close MeetingFor